TY - JOUR T1 - Reduction of brooding and more general depressive symptoms after fMRI neurofeedback targeting a melancholic functional-connectivity biomarker JF - medRxiv DO - 10.1101/2021.01.21.20248810 SP - 2021.01.21.20248810 AU - Jessica Elizabeth Taylor AU - Takashi Yamada AU - Takahiko Kawashima AU - Yuko Kobayashi AU - Yujiro Yoshihara AU - Jun Miyata AU - Toshiya Murai AU - Mitsuo Kawato AU - Tomokazu Motegi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/26/2021.01.21.20248810.abstract N2 - Depressive disorders contribute heavily to global disease burden; This is possibly because patients are usually treated homogeneously, despite having heterogeneous symptoms with differing underlying neural mechanisms. On the contrary, treatment that directly influences the neural circuit relevant to an individual patient’s subset of symptoms might more precisely and thus effectively aid in the alleviation of their specific symptoms. We tested this hypothesis, using fMRI functional connectivity neurofeedback to target a neural biomarker that objectively relates to a specific subset (melancholic) of depressive symptoms and that is generalizable across independent cohorts of patients. The targeted biomarker was the functional connectivity between the left dorsolateral prefrontal cortex and left precuneus, which has been shown in a data-driven manner to be less anticorrelated in patients with melancholic depression than in healthy controls. We found that the more a participant normalized this biomarker, the more related (brooding and more general depressive), but not unrelated (trait anxiety), symptoms were reduced. Thus, one-to-one correspondence between a normalized neural network and decreased depressive symptoms was demonstrated. These results were found in two experiments that took place several years apart by different experimenters, indicating their reproducibility. Indicative of their potential clinical utility, effects remained one-two months later.Competing Interest StatementTY and MK are inventors of patents related to the functional connectivity neurofeedback method. The original assignee of the patents is ATR, with which the authors are affiliated. We have no other conflicts of interest.Clinical TrialUMIN000015249 jRCTs052180169Funding StatementThis study was conducted under the contract research 'Brain/MINDS Beyond', Grant Number JP18dm0307008, supported by the Japan Agency for Medical Research and Development (AMED). It was also supported by 'Application of DecNef for Development of Diagnostic and Cure System for Mental Disorders and Construction of Clinical Application Bases' under 'Development of BMI Technologies for Clinical Application' of the Strategic Research Program for Brain Sciences, Grant Number JP17dm0107044 (AMED), and Innovative Science and Technology Initiative for Security, ATLA, Japan, Grant Number JPJ004596. T.Y. was partially supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research, Grant number 16K10236, and grants from SENSHIN Medical Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the Review Board of Advanced Telecommunications Research Institute International, Japan, and by the Kyoto University Certified Review Board (UMIN000015249, CRB5180002).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and analysed during the current study are not publicly available due to restrictions of their containing information that could compromise the privacy of research participants. But the datasets are available from the corresponding author on reasonable request. ER -